tiprankstipranks
Poseida Therapeutics (PSTX)
NASDAQ:PSTX

Poseida Therapeutics (PSTX) Financial Statements

432 Followers

Poseida Therapeutics Financial Overview

Poseida Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.18; its P/E ratio is -2.55; Poseida Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 28.14M$ 25.00M$ 9.35M$ 20.01M$ 10.34M
Gross Profit$ 28.14M$ 25.00M$ 9.35M$ 20.01M$ 10.34M
EBIT$ -22.02M$ -23.08M$ -29.43M$ -25.32M$ -36.82M
EBITDA$ -20.64M$ -21.64M-$ -25.83M$ -37.48M
Net Income Common Stockholders$ -24.27M$ -25.35M$ -31.78M$ -27.46M$ -38.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 198.65M$ 212.20M$ 238.84M$ 214.61M$ 247.20M
Total Assets$ 262.58M$ 273.88M$ 302.25M$ 281.21M$ 313.62M
Total Debt$ 84.56M$ 85.42M$ 86.26M$ 87.08M$ 87.89M
Net Debt$ -114.08M$ -126.78M$ -152.58M$ -127.53M$ -159.31M
Total Liabilities$ 177.99M$ 170.18M$ 178.59M$ 145.91M$ 156.06M
Stockholders Equity$ 84.56M$ 103.70M$ 123.66M$ 135.26M$ 157.56M
Cash Flow-
Free Cash Flow$ -15.23M$ -29.05M-$ -34.50M$ -38.81M
Operating Cash Flow$ -15.10M$ -28.74M$ 7.90M$ -33.32M$ -38.03M
Investing Cash Flow$ 24.00M$ 47.71M$ -47.24M$ 43.07M$ -4.42M
Financing Cash Flow$ -43.00K-$ 14.94M-$ 1.19M
Currency in USD

Poseida Therapeutics Earnings and Revenue History

Poseida Therapeutics Debt to Assets

Poseida Therapeutics Cash Flow

Poseida Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis